Analysis of a Pharmacy Developed, Outpatient Lactation Consultant Initiated Domperidone Programme

1. Lebedevs T, Kendrick C. Pharmacological management of common lactation problems. J Res Pharm Pract. 2019;49(2):192–198. doi: 10.1002/jppr.1561 LebedevsT KendrickC Pharmacological management of common lactation problems J Res Pharm Pract 2019 49 2 192 198 10.1002/jppr.1561 Open DOISearch in Google Scholar

2. Wada Y, Suyama F, Amari S, et al. Effects of Domperidone in Increasing Milk Production in Mothers with Insufficient Lactation for Infants in the Neonatal Intensive Care Unit. Breastfeed Med. 2019;14(10):744–747. doi: 10.1089/bfm.2019.0111 WadaY SuyamaF AmariS Effects of Domperidone in Increasing Milk Production in Mothers with Insufficient Lactation for Infants in the Neonatal Intensive Care Unit Breastfeed Med 2019 14 10 744 747 10.1089/bfm.2019.0111 Open DOISearch in Google Scholar

3. Obstetrics and Gynaecology Directorate Women and Newborn Health Services. Newborn Feeding and Maternal Lactation. 2023; Version 2: February 2023. Available from: https://healthpoint.hdwa.health.wa.gov.au/policies/Policies/NMAHS/WNHS/WNHS.OG.NewbornFeedingAndMaternalLactation.pdf Obstetrics and Gynaecology Directorate Women and Newborn Health Services Newborn Feeding and Maternal Lactation. 2023; Version 2 February 2023 Available from: https://healthpoint.hdwa.health.wa.gov.au/policies/Policies/NMAHS/WNHS/WNHS.OG.NewbornFeedingAndMaternalLactation.pdf Search in Google Scholar

4. Department of Health and Aged Care. Domperidone (Motilium) and effects on the heart. Therapeutics Goods Administration. April 2, 2014. Available from: https://www.tga.gov.au/news/safety-alerts/domperidone-motilium-and-effects-heart#:~:text=The%20TGA%20is%20reviewing%20new%20information%20regarding%20domperidone,of%20nausea%20and%20vomiting%2C%20and%20delayed%20stomach%20emptying Department of Health and Aged Care Domperidone (Motilium) and effects on the heart Therapeutics Goods Administration April 2 2014 Available from: https://www.tga.gov.au/news/safety-alerts/domperidone-motilium-and-effects-heart#:~:text=The%20TGA%20is%20reviewing%20new%20information%20regarding%20domperidone,of%20nausea%20and%20vomiting%2C%20and%20delayed%20stomach%20emptying Search in Google Scholar

5. Knoppert DC, Page A, Warren J, et al. The effect of two different domperidone doses on maternal milk production. J Hum Lact. 2013;29(1):38–44. doi: 10.1177/0890334412438961 KnoppertDC PageA WarrenJ The effect of two different domperidone doses on maternal milk production J Hum Lact 2013 29 1 38 44 10.1177/0890334412438961 Open DOISearch in Google Scholar

6. Brodribb W. ABM Clinical Protocol #9: Use of galactogogues in initiating or augmenting maternal milk production, Second Revision 2018. Breastfeed Med. 2018; 13(5):307–314. doi: 10.1089/bfm.2018.29092.wjb BrodribbW ABM Clinical Protocol #9: Use of galactogogues in initiating or augmenting maternal milk production, Second Revision 2018 Breastfeed Med 2018 13 5 307 314 10.1089/bfm.2018.29092.wjb Open DOISearch in Google Scholar

7. Sadovnikova A, Sommers J, Oberhelman S. Preliminary results from a survey of the pharmacologic, herbal, and nutritional galactagogue prescribing practices of physicians in the united states and canada. In: The Academy of Breastfeeding Medicine. Abstracts. 25th Annual International Meeting; 2020 Nov 5–7; Online. SadovnikovaA SommersJ OberhelmanS Preliminary results from a survey of the pharmacologic, herbal, and nutritional galactagogue prescribing practices of physicians in the united states and canada In: The Academy of Breastfeeding Medicine Abstracts. 25th Annual International Meeting 2020 Nov 5–7 Online. Search in Google Scholar

8. Hondeghem LM, Logghe NH. should domperidone be used as a galactagogue? Possible safety implications for mother and child. Drug Safety. 2017;40(2):109–113. doi; 10.1007/s40264-016-0478-x. HondeghemLM LoggheNH should domperidone be used as a galactagogue? Possible safety implications for mother and child Drug Safety 2017 40 2 109 113 10.1007/s40264-016-0478-x Open DOISearch in Google Scholar

9. How to Request Domperidone for Expanded Access Use. US Food & Drug Administration. Updated February 2, 2021. Available from: https://www.fda.gov/drugs/investigational-new-drug-ind-application/how-request-domperidone-expanded-access-use How to Request Domperidone for Expanded Access Use US Food & Drug Administration Updated February 2, 2021. Available from: https://www.fda.gov/drugs/investigational-new-drug-ind-application/how-request-domperidone-expanded-access-use Search in Google Scholar

10. McBride GM, Stevenson R, Zizzo G, et al. Use and experiences of galactagogues while breastfeeding among Australian women. PLoS ONE. 2021;1(16):7. doi: 10.1371/journal.pone.025049 McBrideGM StevensonR ZizzoG Use and experiences of galactagogues while breastfeeding among Australian women PLoS ONE 2021 1 16 7 10.1371/journal.pone.025049 Open DOISearch in Google Scholar

11. Tauritz Bakker LA, van Dijk L, van den Bemt PMLA. Exploring the prescribing process of domperidone for low milk supply: A qualitative study among mothers, IBCLCs, and family doctors. J Hum Lact. 2021;37(4):748–760. doi:10.1177/0890334420964070 Tauritz BakkerLA van DijkL van den BemtPMLA Exploring the prescribing process of domperidone for low milk supply: A qualitative study among mothers, IBCLCs, and family doctors J Hum Lact 2021 37 4 748 760 10.1177/0890334420964070 Open DOISearch in Google Scholar

12. Grzeskowiak LE. Audit of domperidone use as a galactogogue at a major tertiary teaching hospital. J Paediatr Child Health. 2012;48(1):8–81. GrzeskowiakLE Audit of domperidone use as a galactogogue at a major tertiary teaching hospital J Paediatr Child Health 2012 48 1 8 81 Search in Google Scholar

13. Mehrabadi A, Reynier P, Root A, Platt RW, Filion KB. The use of domperidone for insufficient lactation in England between 2002 and 2015: A drug utilization study with interrupted time-series analysis. Pharmacoepidemiol Drug Saf. 2017;26(suppl 2):579. doi: 10.1002/pds MehrabadiA ReynierP RootA PlattRW FilionKB The use of domperidone for insufficient lactation in England between 2002 and 2015: A drug utilization study with interrupted time-series analysis Pharmacoepidemiol Drug Saf 2017 26 suppl 2 579 10.1002/pds Open DOISearch in Google Scholar

14. Khorana M, Wongsin P, Torbunsupachai R, Kanjanapattanakul W. effect of domperidone on breast milk production in mothers of sick neonates: A randomized, double-blinded, placebo-controlled trial. Breastfeed Med. 2021;16(3):245–250. doi:10.1089/bfm.2020.0234 KhoranaM WongsinP TorbunsupachaiR KanjanapattanakulW effect of domperidone on breast milk production in mothers of sick neonates: A randomized, double-blinded, placebo-controlled trial Breastfeed Med 2021 16 3 245 250 10.1089/bfm.2020.0234 Open DOISearch in Google Scholar

15. Grzeskowiak LE, Amir LH. Pharmacological management of low milk supply with domperidone: separating fact from fiction. Med J Aust. 2014;201(5):257–258. doi: 10.5694/mja14.00626 GrzeskowiakLE AmirLH Pharmacological management of low milk supply with domperidone: separating fact from fiction Med J Aust 2014 201 5 257 258 10.5694/mja14.00626 Open DOISearch in Google Scholar

16. Asztalos EV, Kiss A, da Silva OP, Campbell-Yeo M, Ito S, Knoppert D. Evaluating the effect of a 14-day course of domperidone on breast milk production: A per-protocol analysis from the EMPOWER trial. Breastfeed Med. 2019;14(2):102–107. doi: 10.1089/bfm.2018.0175 AsztalosEV KissA da SilvaOP Campbell-YeoM ItoS KnoppertD Evaluating the effect of a 14-day course of domperidone on breast milk production: A per-protocol analysis from the EMPOWER trial Breastfeed Med 2019 14 2 102 107 10.1089/bfm.2018.0175 Open DOISearch in Google Scholar

17. Taylor A, Logan G, Twells L, Newhook LA. Human milk expression after domperidone treatment in postpartum women: A systematic review and meta-analysis of randomized controlled trials. J Hum Lact. 2019;35(3):501–509. doi: 10.1177/0890334418812069 TaylorA LoganG TwellsL NewhookLA Human milk expression after domperidone treatment in postpartum women: A systematic review and meta-analysis of randomized controlled trials J Hum Lact 2019 35 3 501 509 10.1177/0890334418812069 Open DOISearch in Google Scholar

18. Foong SC, Tan ML, Foong WC, Marasco LA, Ho JJ, Ong JH. Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants. Cochrane Database Syst Rev. 2020;(5):CD011505. doi: 10.1002/14651858.CD011505.pub2 FoongSC TanML FoongWC MarascoLA HoJJ OngJH Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants Cochrane Database Syst Rev 2020 5 CD011505 10.1002/14651858.CD011505.pub2 Open DOISearch in Google Scholar

19. Asztalos EV, Campbell-Yeo M, da Silva OP, et al. Enhancing human milk production with domperidone in mothers of preterm infants: Results from the EMPOWER trial. J Hum Lact. 2017;33(1):181–187. doi:10.1177/0890334416680176 AsztalosEV Campbell-YeoM da SilvaOP Enhancing human milk production with domperidone in mothers of preterm infants: Results from the EMPOWER trial J Hum Lact 2017 33 1 181 187 10.1177/0890334416680176 Open DOISearch in Google Scholar

20. Doyle M, Grossman M. Case report: domperidone use as a galactagogue resulting in withdrawal symptoms upon discontinuation. Arch Women’s Men Health. 2018;21(4):461–463. doi: 10.1007/s00737-017-0796-8 DoyleM GrossmanM Case report: domperidone use as a galactagogue resulting in withdrawal symptoms upon discontinuation Arch Women’s Men Health 2018 21 4 461 463 10.1007/s00737-017-0796-8 Open DOISearch in Google Scholar

21. Smolina K, Mintzes B, Hanley GE, Oberlander TF, Morgan SG. The association between domperidone and ventricular arrhythmia in the postpartum period. Pharmacoepidemiol Drug Saf. 2016;25(10):1210–1214. doi:10.1002/pds.4035 SmolinaK MintzesB HanleyGE OberlanderTF MorganSG The association between domperidone and ventricular arrhythmia in the postpartum period Pharmacoepidemiol Drug Saf 2016 25 10 1210 1214 10.1002/pds.4035 Open DOISearch in Google Scholar

22. Hasse B, Taylor SN, Mauldin J, Johnson TS, Wagner CL. Domperidone for treatment of low milk supply in breast pump–dependent mothers of hospitalized premature infants: A clinical protocol. J Hum Lact. 2016;32(2):373–381. doi: 10.1177/0890334416630539 HasseB TaylorSN MauldinJ JohnsonTS WagnerCL Domperidone for treatment of low milk supply in breast pump–dependent mothers of hospitalized premature infants: A clinical protocol J Hum Lact 2016 32 2 373 381 10.1177/0890334416630539 Open DOISearch in Google Scholar

23. Andrew B, Smith R. Domperidone safety checklist [leaflet]. Adelaide Mums and Babies Clinic; 2019. AndrewB SmithR Domperidone safety checklist [leaflet] Adelaide Mums and Babies Clinic 2019 Search in Google Scholar

24. Gilmartin CE, Amir LH, Ter M, Grzeskowiak LE. Using domperidone to increase breast milk supply: A clinical practice survey of Australian neonatal units. J Res Pharm Pract. 2017;47(6):426–430. GilmartinCE AmirLH TerM GrzeskowiakLE Using domperidone to increase breast milk supply: A clinical practice survey of Australian neonatal units J Res Pharm Pract 2017 47 6 426 430 Search in Google Scholar

25. Government of Western Australia. Structured administration and supply arrangements. Department of Health. 2023. Available from: https://www.health.wa.gov.au/Articles/S_T/Structured-Administration-and-Supply-Arrangements Government of Western Australia Structured administration and supply arrangements Department of Health 2023 Available from: https://www.health.wa.gov.au/Articles/S_T/Structured-Administration-and-Supply-Arrangements Search in Google Scholar